Amelia Feulner Baur Ph.D.
Amelia Baur practices client counseling and patent prosecution, and has extensive experience in reexaminations and interferences. She has been practicing in these areas for 10 years, first as a patent agent and now as a senior associate. Dr. Baur has a special interest in counseling clients on patent application filing and developing worldwide prosecution strategies. She provides a full range of patent prosecution and counseling services to clients and develops patent strategies in concert with clients' business goals. She has worked with biotech start-ups, research foundations, and larger, established pharmaceutical companies.
Dr. Baur's counseling and prosecution practice includes providing strategic advice and preparing patentability, validity, enforceability, and infringement opinions, new patent applications, and prosecuting both U.S. and foreign applications. She also has considerable experience managing and directing U.S. and international patent portfolios for U.S. clients and overseeing U.S. patent portfolios for international clients in Europe and Asia.
Dr. Baur has represented the patent owner in four related inter partes reexaminations, and has been integral in procuring and defending patents involving the human immunodeficiency virus (HIV) and the human papillomavirus (HPV). She has assisted in all aspects of interference proceedings at the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office (PTAB) (formerly the Board of Patent Appeals and Interferences), and has experience in the settlement of patent disputes.
Dr. Baur earned her Ph.D. degree in molecular microbiology, where she gained extensive hands-on experience in the fields of microbiology, immunology, biochemistry, molecular biology, and infectious disease. She has substantial legal experience in many biotechnology and pharmaceutical practice areas including antibodies and antibody variants, diagnostic and detection methods, protein purification, vaccine technology, fusion proteins, gene cloning and expression, and gene and protein mutations.
- Managed and directed a complex U.S. and international patent portfolio for a U.S pharmaceutical client relating to the treatment of muscular disorders using antibodies and small molecule inhibitors.
- Took a lead role in a team that represented the patent owner in four related inter partes reexaminations relating to homologous recombination technology; responsible for all interactions with two experts.
- Directed the U.S. prosecution for nobel laureates in obtaining patents relating to the human immunodeficiency virus (HIV).
- Responsible for managing the expert declarants relating to the settlement of longstanding patent interference proceedings; drafted all expert declarations.
- Represented university client in an interference proceeding relating to a vaccine for human papillomavirus (HPV).
- Supported a disabled American veteran in an appeal to the U.S. Court of Appeals for Veteran Claims.
- Boston Patent Law Association
- American Bar Association
- Pennsylvania Bar Association
- Coauthor. "Personalized Medicine Patents at Risk: Tips for Battling Prometheus and Myriad to Obtain Claims to Diagnostics," CIPA Journal, March 2013.
- Coauthor. "Patenting Personalized Medicine," The Journal of Biolaw and Business, 2006.
- Coauthor. "Creating and Enforcing Patent Rights in the Fast Moving Field of Personalized Medicine," Personalized Medicine, Feb. 2006.
- Coauthor. "Identification of Acyloxyacyl Hydrolase, a LipopolySaccharide-Detoxifying Enzyme, in the Murine Urinary Tract," Infection and Immunity, June 2004.